Mouse model of human infertility: Transient and local inhibition of endometrial STAT-3 activation results in implantation failure  by Nakamura, Hitomi et al.
FEBS Letters 580 (2006) 2717–2722Mouse model of human infertility: Transient and local inhibition
of endometrial STAT-3 activation results in implantation failure
Hitomi Nakamuraa,1, Tadashi Kimuraa,*, Shinsuke Koyamaa, Kazuhide Ogitaa, Tateki Tsutsuia,
Koichiro Shimoyaa, Takeshi Taniguchib, Masayasu Koyamaa, Yasufumi Kanedac, Yuji Murataa
a Division of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 5650871, Japan
b Taniguchi Hospital, 1-5-20, Ohnishi, Izumisano, Osaka 5980043, Japan
c Division of Gene Therapy Science, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 5650871, Japan
Received 22 February 2006; revised 6 April 2006; accepted 7 April 2006
Available online 21 April 2006
Edited by Robert BaroukiAbstract Embryo implantation involves a series of biochemical
reactions and its failure is an important therapeutic target of
infertility treatment. We established an infertile mouse model
using transient and local suppression of signal transducer and
activator of transcription-3 (STAT-3) activity by STAT-3 decoy
transfer into the uterine cavity during implantation, resulting in
<30% implantation. This infertility is caused by suppression of
decidualization, which is indispensable for implantation, and
independent of progesterone. These conditions may mimic clini-
cally unexplained infertility. Our results suggest that STAT-3
could be a useful target for diagnosis and therapy of human
implantation failure.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Approximately 10–15% of all couples experience infertility
during their reproductive lives [1]. Implantation failure is con-
sidered to be a major reason for their infertility. One third of
implantation failures might be attributed to the embryo itself.
The remaining 2/3 of failures appear to be the result of inade-
quate uterine receptivity [2]. It is thus important to improve
uterine receptivity in infertility treatment. However, the path-
ophysiology of implantation failure is unexplained as is the
molecular mechanism of implantation. Uterine receptivity
has been clinically evaluated via serum progesterone levels,
ultrasonographic endometrial thickness, and histological dat-
ing by endometrial biopsy [3]. A discrepancy between the hor-
monal milieu and endometrial morphology and/or function
could be an important cause of implantation failure [4],Abbreviations: STAT-3, signal transducer and activator of transcrip-
tion-3; LIF, leukemia inhibitory factor; IL, interleukin; HVJ-E, (he-
magglutinating virus of Japan, also known as Sendai virus)-envelope;
HTF, human tubal ﬂuid medium; ODN, oligodeoxynucleotide
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to date. We hypothesize that a few multi-potential transcrip-
tional factors might initiate the regulatory cascade and have
pivotal roles in generating the implantation window. There-
fore, we devised a local and transient in vivo gene transfer sys-
tem to modulate the function of endometrial signaling
molecules during the implantation window, without disturbing
the course of pregnancy [5]. STATs are a family of latent cyto-
plasmic proteins involved in transmitting extra-cellular signals
to the nucleus [6]. Signal transducer and activator of transcrip-
tion-3 (STAT-3) is activated by gp130, a subunit of the recep-
tor for the interleukin-6 (IL-6) family of cytokines, including
leukemia inhibitory factor (LIF) and IL-11. As gene targeting
analysis indicated LIF and IL-11 play crucial roles in implan-
tation [7,8], the physiological function of STAT-3 activation in
implantation is of great interest. However, STAT-3 deﬁciency
in embryos is lethal, and obtaining adult STAT-3 null female
mice impossible [9]. Here, we perturbed STAT-3 activation
in the mouse uterus during the implantation period using a
STAT3-decoy/transient in vivo DNA transfer system to estab-
lish an implantation failure model.2. Materials and methods
2.1. Animals
Female ICR mice (SLC, Shizuoka, Japan) aged 8–10 weeks in estrus
were bred with male ICR mice, and the morning when vaginal plug-
ging was observed was designated as day 0.5 post coitus (p.c.). Animal
experiments were performed according to the guidelines for animal use
approved by the Institutional Animal Care and Use Committee of
Osaka University Graduate School of Medicine.
2.2. STAT-3 decoy transfer
A STAT-3 binding consensus sequence which acts as a decoy cis-ele-
ment (5 0-CCTTCCGGGAATTCCTTCCGGGAATTC-3 0; underlines
indicate consensus element) [10] and a scramble sequence (5 0-
AGTCCATTCGGCAGGCCTCTGCTCTAT-3 0), were synthesized
as phosphorotioate-modiﬁed oligodeoxynucleotides (ODNs), and
puriﬁed by HPLC (Hokkaido System Science, Sapporo, Japan). Decoy
ODNs were prepared by annealing of sense and antisense ODNs. Dou-
ble stranded decoy ODNs were transferred to the murine uterus by
HVJ-E vector (GenomONE-NEO, Ishihara Sangyo Co. Ltd. Osaka,
Japan) as described previously [5,11].
2.3. Tissue sampling and analysis of implantation/course of pregnancy
The mice on day 5.0 p.c., after in vivo gene transfer, were sacriﬁced
by administration of excess anesthetic. The uteri were removed and
frozen in liquid nitrogen. Day 5.0 p.c. pregnant animals received anblished by Elsevier B.V. All rights reserved.
Fig. 1. Eﬀect of STAT-3 decoy transfer in mouse uterus. The mice had
vehicle (HTF), scramble or STAT-3 decoy transferred on day 1.5 p.c.
(A) STAT-3 activity in nuclear extract from whole uterus at 5.0 p.c.
Each group consisted of at least 5 mice. All bars represent the
mean ± S.E.M. *P < 0.0005 by the Mann–Whitney U test. (B) Preg-
nancy rate on day 15.5 p.c. *P < 0.05 by the Mann–Whitney U test.
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implantation sites [12]. The serum progesterone level on day 5.0 p.c.
was measured using a DPC progesterone RIA kit (Diagnostic Produc-
tion Co. Ltd., LA, USA).
2.4. Activity assay of active STAT-3
Nuclear proteins from uterine tissue were prepared as described [13].
Nuclear extract was aliquoted, frozen in liquid nitrogen and stored at
80 C. Protein concentration was determined using a protein assay
kit (Bio-Rad Laboratories, Inc. CA) and the amount of activated
STAT-3 was assayed using intracellular DuoSet IC (R&D systems,
Inc. MN), according to the manufacturer’s instructions.
2.5. Detection of transfected DNA in embryos
The cDNA of murine STAT-3 Y705 F, a dominant negative mutant
of STAT-3, was distributed from RIKEN BRC DNA Bank (RDB &
2354). The open reading frame of STAT-3 Y705F was excised and
introduced into pcDNA3 (Invitrogen, San Diego, CA) (pcDNA3-
STAT-3 Y705F). Plasmid DNA was puriﬁed using a Qiagen column
(Tokyo, Japan). Transfection of pcDNA3-STAT-3 Y705F with HVJ-
E vector was preformed as previously described [11] and blastocysts
were ﬂushed out from the uterus on day 4.0 p.c. The DNA was
extracted from each single blastocyst and PCR was performed as
described previously [11].
2.6. Induction of decidualization
To induce experimental decidualization, pseudopregnant female
mice mated with vasectomized male mice received an intraluminal
infusion of 10 ll sesame oil in one uterine horn on day 3.5 p.c. and
were sacriﬁced after 72 h as described by Rider et al. [14].
2.7. RT-PCR
Total RNA was extracted by using TRIZOL (Invitrogen). Single-
stranded cDNA was synthesized from 3 lg of total RNA using Super-
ScriptII (Invitrogen). The PCR for progesterone receptor-A was per-
formed using rTaq DNA polymerase (Toyobo, Osaka, Japan) as
described by Clemens et al. [15].
2.8. Statistical evaluation of results
Statistical analysis was performed using the Mann–Whitney U test.3. Results and discussion
3.1. Transfection of STAT-3 decoy suppressed STAT-3 activity
and pregnancy
STAT-3 activity in the uterine nuclear extract on day 5.0 p.c.
after STAT-3 decoy transfection was signiﬁcantly suppressed
compared to control uteri (Fig. 1A). On day 15.5 p.c., we
examined viable fetuses in utero. In the group treated with
vehicle (human tubal ﬂuid medium, HTF) and scramble decoy,
all mice became pregnant. However, in mice treated with the
STAT-3 decoy, approximately 70% of mice lacked viable fe-
tuses (Fig. 1B). An alternative STAT-3 decoy with the single
cis-binding sequence, (5 0-GATCCTTCTGGGAATTCCTA-
GATC-3 0, 3 0-CTAGGAAGACCCTTAAGGATCTAG-5 0,
consensus sequences) failed to suppress pregnancy (100% of
mice became pregnant after transfection; data not shown).
Using this gene transfer method, we previously showed that
the transferred gene did not aﬀect embryos and the course of
pregnancy, i.e., in luciferase cDNA transferred mice, embryos
developed and were delivered normally [11] and IjBaM
cDNA, a dominant negative mutant of IjB to suppress the
activation of nuclear factor jB, transferred mice delivered their
pups 1 day after the normal due date [5]. We ﬂushed out nor-
mal blastocysts on 4.0 p.c. from STAT-3 decoy transfer uteri
(Fig. 2A), although no embryo was recovered from scrambledecoy or pcDNA3 transferred uterus on 4.0 p.c. The trans-
ferred gene after pcDNA3-STAT-3 Y705F was undetectable
in ﬂushed out embryos by PCR (Fig. 2B). These previous
and present observations showed that STAT-3 decoy transfer
had neither killed the blastocysts nor washed them out through
the uterus.
In the STAT-3 decoy transfer group, 75% of mice did not ex-
hibit implantation sites on day 5.0 p.c. detected by Evans Blue.
In the scramble decoy transfer group, implantation sites were
evident in all mice (Fig. 3A and B). On day 8.0 p.c., in control
uteri, embryos had already formed primitive somites. How-
ever, decidualization was apparently disturbed in the STAT-
3 decoy treated uterus (Fig. 3C), indicating that decreased
implantation sites on day 5.0 p.c. were not due to delayed
implantation of dormant embryos. Therefore, STAT-3 sup-
pression led infertility was caused by inadequate uterine recep-
tivity, i.e., implantation failure.
3.2. Decidualization response
As decidualization was totally inhibited in the STAT-3 de-
coy transfected uterus on day 8.0 p.c., we examined the eﬀect
of STAT-3 suppression on mechanical decidualization. The
decidual response was obviously suppressed in the STAT-3
decoy transfected uterus (Fig. 4A and B).
Fig. 2. Eﬀect of the gene transfer on embryo. (A) On day 4.0 p.c.,
blastocysts were ﬂushed out from STAT-3 decoy transferred uterus.
The blastocysts showed normal morphology. No blastocyst was
ﬂushed out from scramble transferred uteri. (B) On the same day,
blastocysts were collected from pcDNA3-STAT-3 Y705F transfer
group. Single blastocyst DNA PCR for pcDNA3-STAT-3 Y705F was
performed. The amplicon from 1 and 10 fg of plasmid DNA could be
detected under PCR conditions (lanes 6 and 7). In the genomic DNA
extracted from the blastocyst, the amplicon of plasmid DNA was
undetectable (lanes 1–5).
Fig. 3. Eﬀect of the gene transfer on the stage of implantation. (A)
Implantation sites determined by an i.v. injection of Evans Blue on day
5.0 p.c. Scramble decoy transferred uteri (a) and STAT-3 decoy
transferred uteri (b). Blue-stained ovaries indicate both ends of the
uterus in (b). In (a), ovaries were removed. (B) The numbers of
implantation sites on day 5.0 p.c. *P < 0.01 by the Mann–Whitney U
test. (C) Hematoxylin and eosin staining of the uterus at day 8.0 p.c.
Scramble decoy transfer group (a, c) STAT-3 decoy transfer group (b,
d). Scale bars: (a) 1 mm; (b) 500 lm; (c) 250 lm and (d) 100 lm.
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Progesterone is indispensable for successful embryo implan-
tation and decidualization. After STAT-3 decoy transfection,
ovarian morphology (Fig. 5A), progesterone levels in the
peripheral blood (Fig. 5B), and uterine progesterone recep-
tor-A mRNA levels (Fig. 5C) were similar to the scramble de-
coy transfer group, indicating that the implantation failure was
not associated with alteration of the progesterone signaling.
During infertility treatment of women, we often noticed a sim-
ilar condition, in which women cannot conceive despite nor-
mal progesterone levels. Our mouse model may reﬂect the
discrepancy between hormonal milieu and endometrial func-
tion [4]. The suppression level of STAT-3 activity in the uterus
by STAT-3 decoy on day 5.0 p.c. was approximately 50%. This
model may more accurately represent the clinical situation
than a full gene depletion model, because a large subset of
unexplained infertility is idiopathic but not irreversible [1].
Endometrial dating by histological morphology is unreliable
for predicting the outcome of infertility treatment [16,17],
therefore a functional target to indicate uterine receptivity
was investigated. The relationship between LIF concentration
in the uterine cavity during secretory phase and infertility has
been examined extensively with inconclusive results [18–21].
Point mutation/polymorphism of the LIF gene in infertile pa-
tients has been reported [22], although its functional signiﬁ-
cance is unclear. Sherwin et al. [23] reported that soluble
gp130 up-regulation in mid-secretory phase was suppressed
in infertile patients. We still do not have a molecular marker
that can be used to clinically evaluate uterine receptivity.
STAT-3 is activated by the IL-6 family of cytokines. Among
the family, only LIF and IL-11 receptor-a knockout mice had
an implantation failure phenotype [7,8,24]. LIF and IL-11exhibit a diﬀerent temporal expression pattern; i.e., LIF
expression peaks just before the implantation window, whilst
IL-11 expression peaks on day 5.5–7.5 p.c. [8]. Both signals
are transduced via gp130 to either of the STAT-1/3 or SHP2/
ERK pathways. Transgenic knock-in mouse with defective
gp130-mediated STAT-1/3 signaling caused implantation fail-
ure [25]. STAT-3 activation just prior to implantation has also
been observed in murine and rat uterine endometrium [26,27].
An administration of cell membrane permeable STAT-3 inhib-
itor had a contraceptive eﬀect and revealed gene down-regula-
Fig. 4. Experimentally induced decidualization. (A) Histological examination 72 h after oil injection revealed deciduoma formation (a, c) many
decidualized cells (c) in scramble decoy transfected uterus. STAT-3 decoy transferred uterus was smaller than control and (b) there were many glands
and less characterized decidualization (d). Scale bars: (a, b) 500 lm; (c, d) 100 lm and (e, f) 50 lm. (B) Fold-increase of uterine wet weights, measured
72 h after oil injection. All bars represent the mean ± S.E.M. from at least ﬁve animals. *P = 0.002.
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Taken together with our present data, full activation of
STAT-3, rather than signaling via STAT-1 and SHP2/ERKare necessary for uterine receptivity. In a preliminary study
we tested the activation of STAT-3 in human endometrium
from unexplained infertile women. As activation of STAT-3
Fig. 5. Ovarian function. (A) On day 5.0 p.c. in both ovaries, corpus
luteums were obvious and no signiﬁcant diﬀerence was observed after
scramble decoy (a) and STAT-3 decoy (b) transfection. (B) Progester-
one levels in peripheral blood on day 5.0 p.c. were similar in STAT-3
and scramble decoy transfer groups. Bars represent the mean ± S.E.M.
from at least ﬁve animals. (C) The level of progesterone receptor (PR)-
A transcripts in uterus on day 5.0 p.c. were similar in vehicle (HTF),
scramble decoy and STAT-3 decoy transferred groups.
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some infertile patients (unpublished data), STAT-3 could be
one of the diagnostic and therapeutic targets for unexplained
infertility along with IL-11 [7,8,24] and Wnt/b-catenin signal-
ing [30]. Transcription factors comprise useful molecular ther-
apies to improve fertility or alternatively to achieve
contraception. The uterus is a tubular organ and its inner
endometrial surface is accessible via the cervix, therefore the
endometrium could be a good candidate for local, transient
molecular target therapy. Our in vivo gene transfer system into
the mouse uterus has proven to be a good experimental tool
for mining the opportunities for molecular therapy of implan-
tation failure.
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